img

Global Gastrointestinal Drugs Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Gastrointestinal Drugs Market Research Report 2024

Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
According to Mr Accuracy reports new survey, global Gastrointestinal Drugs market is projected to reach US$ 43470 million in 2029, increasing from US$ 34710 million in 2022, with the CAGR of 3.2% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gastrointestinal Drugs market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Gastrointestinal Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


AstraZeneca
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria (Tillotts)
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen
Segment by Type
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug

Segment by Application


Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Other

Consumption by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Gastrointestinal Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Gastrointestinal Drugs Market Overview
1.1 Product Overview and Scope of Gastrointestinal Drugs
1.2 Gastrointestinal Drugs Segment by Type
1.2.1 Global Gastrointestinal Drugs Market Value Comparison by Type (2024-2034)
1.2.2 Prescription Gastrointestinal Drug
1.2.3 OTC Gastrointestinal Drug
1.3 Gastrointestinal Drugs Segment by Application
1.3.1 Global Gastrointestinal Drugs Market Value by Application: (2024-2034)
1.3.2 Chronic Gastritis
1.3.3 Functional Dyspepsia
1.3.4 Peptic Ulcer
1.3.5 Acute Gastroenteritis
1.3.6 Other
1.4 Global Gastrointestinal Drugs Market Size Estimates and Forecasts
1.4.1 Global Gastrointestinal Drugs Revenue 2018-2029
1.4.2 Global Gastrointestinal Drugs Sales 2018-2029
1.4.3 Global Gastrointestinal Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Gastrointestinal Drugs Market Competition by Manufacturers
2.1 Global Gastrointestinal Drugs Sales Market Share by Manufacturers (2018-2024)
2.2 Global Gastrointestinal Drugs Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Gastrointestinal Drugs Average Price by Manufacturers (2018-2024)
2.4 Global Gastrointestinal Drugs Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Gastrointestinal Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gastrointestinal Drugs, Product Type & Application
2.7 Gastrointestinal Drugs Market Competitive Situation and Trends
2.7.1 Gastrointestinal Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gastrointestinal Drugs Players Market Share by Revenue
2.7.3 Global Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gastrointestinal Drugs Retrospective Market Scenario by Region
3.1 Global Gastrointestinal Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Gastrointestinal Drugs Global Gastrointestinal Drugs Sales by Region: 2018-2029
3.2.1 Global Gastrointestinal Drugs Sales by Region: 2018-2024
3.2.2 Global Gastrointestinal Drugs Sales by Region: 2024-2029
3.3 Global Gastrointestinal Drugs Global Gastrointestinal Drugs Revenue by Region: 2018-2029
3.3.1 Global Gastrointestinal Drugs Revenue by Region: 2018-2024
3.3.2 Global Gastrointestinal Drugs Revenue by Region: 2024-2029
3.4 North America Gastrointestinal Drugs Market Facts & Figures by Country
3.4.1 North America Gastrointestinal Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Gastrointestinal Drugs Sales by Country (2018-2029)
3.4.3 North America Gastrointestinal Drugs Revenue by Country (2018-2029)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Gastrointestinal Drugs Market Facts & Figures by Country
3.5.1 Europe Gastrointestinal Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Gastrointestinal Drugs Sales by Country (2018-2029)
3.5.3 Europe Gastrointestinal Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gastrointestinal Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Gastrointestinal Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Gastrointestinal Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Gastrointestinal Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gastrointestinal Drugs Market Facts & Figures by Country
3.7.1 Latin America Gastrointestinal Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Gastrointestinal Drugs Sales by Country (2018-2029)
3.7.3 Latin America Gastrointestinal Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gastrointestinal Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Gastrointestinal Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Gastrointestinal Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Gastrointestinal Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gastrointestinal Drugs Sales by Type (2018-2029)
4.1.1 Global Gastrointestinal Drugs Sales by Type (2018-2024)
4.1.2 Global Gastrointestinal Drugs Sales by Type (2024-2029)
4.1.3 Global Gastrointestinal Drugs Sales Market Share by Type (2018-2029)
4.2 Global Gastrointestinal Drugs Revenue by Type (2018-2029)
4.2.1 Global Gastrointestinal Drugs Revenue by Type (2018-2024)
4.2.2 Global Gastrointestinal Drugs Revenue by Type (2024-2029)
4.2.3 Global Gastrointestinal Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Gastrointestinal Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Gastrointestinal Drugs Sales by Application (2018-2029)
5.1.1 Global Gastrointestinal Drugs Sales by Application (2018-2024)
5.1.2 Global Gastrointestinal Drugs Sales by Application (2024-2029)
5.1.3 Global Gastrointestinal Drugs Sales Market Share by Application (2018-2029)
5.2 Global Gastrointestinal Drugs Revenue by Application (2018-2029)
5.2.1 Global Gastrointestinal Drugs Revenue by Application (2018-2024)
5.2.2 Global Gastrointestinal Drugs Revenue by Application (2024-2029)
5.2.3 Global Gastrointestinal Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Gastrointestinal Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2024)
6.1.4 AstraZeneca Gastrointestinal Drugs Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Sanofi Gastrointestinal Drugs Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Bayer Gastrointestinal Drugs Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Pfizer Gastrointestinal Drugs Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2024)
6.5.4 GlaxoSmithKline Gastrointestinal Drugs Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Teva Gastrointestinal Drugs Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Zeria (Tillotts)
6.6.1 Zeria (Tillotts) Corporation Information
6.6.2 Zeria (Tillotts) Description and Business Overview
6.6.3 Zeria (Tillotts) Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Zeria (Tillotts) Gastrointestinal Drugs Product Portfolio
6.7.5 Zeria (Tillotts) Recent Developments/Updates
6.8 Perrigo
6.8.1 Perrigo Corporation Information
6.8.2 Perrigo Description and Business Overview
6.8.3 Perrigo Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Perrigo Gastrointestinal Drugs Product Portfolio
6.8.5 Perrigo Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Corporation Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Boehringer Ingelheim Gastrointestinal Drugs Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
6.10 Purdue Pharma
6.10.1 Purdue Pharma Corporation Information
6.10.2 Purdue Pharma Description and Business Overview
6.10.3 Purdue Pharma Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Purdue Pharma Gastrointestinal Drugs Product Portfolio
6.10.5 Purdue Pharma Recent Developments/Updates
6.11 C.B. Fleet
6.11.1 C.B. Fleet Corporation Information
6.11.2 C.B. Fleet Gastrointestinal Drugs Description and Business Overview
6.11.3 C.B. Fleet Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2024)
6.11.4 C.B. Fleet Gastrointestinal Drugs Product Portfolio
6.11.5 C.B. Fleet Recent Developments/Updates
6.12 Abbott
6.12.1 Abbott Corporation Information
6.12.2 Abbott Gastrointestinal Drugs Description and Business Overview
6.12.3 Abbott Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Abbott Gastrointestinal Drugs Product Portfolio
6.12.5 Abbott Recent Developments/Updates
6.13 Jiangzhong
6.13.1 Jiangzhong Corporation Information
6.13.2 Jiangzhong Gastrointestinal Drugs Description and Business Overview
6.13.3 Jiangzhong Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Jiangzhong Gastrointestinal Drugs Product Portfolio
6.13.5 Jiangzhong Recent Developments/Updates
6.14 Xian-Janssen
6.14.1 Xian-Janssen Corporation Information
6.14.2 Xian-Janssen Gastrointestinal Drugs Description and Business Overview
6.14.3 Xian-Janssen Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Xian-Janssen Gastrointestinal Drugs Product Portfolio
6.14.5 Xian-Janssen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gastrointestinal Drugs Industry Chain Analysis
7.2 Gastrointestinal Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gastrointestinal Drugs Production Mode & Process
7.4 Gastrointestinal Drugs Sales and Marketing
7.4.1 Gastrointestinal Drugs Sales Channels
7.4.2 Gastrointestinal Drugs Distributors
7.5 Gastrointestinal Drugs Customers
8 Gastrointestinal Drugs Market Dynamics
8.1 Gastrointestinal Drugs Industry Trends
8.2 Gastrointestinal Drugs Market Drivers
8.3 Gastrointestinal Drugs Market Challenges
8.4 Gastrointestinal Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Gastrointestinal Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Gastrointestinal Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Gastrointestinal Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Gastrointestinal Drugs Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Gastrointestinal Drugs Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Gastrointestinal Drugs Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Gastrointestinal Drugs Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Gastrointestinal Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Gastrointestinal Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Gastrointestinal Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gastrointestinal Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Gastrointestinal Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gastrointestinal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gastrointestinal Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Gastrointestinal Drugs Sales by Region (2018-2024) & (K Units)
Table 18. Global Gastrointestinal Drugs Sales Market Share by Region (2018-2024)
Table 19. Global Gastrointestinal Drugs Sales by Region (2024-2029) & (K Units)
Table 20. Global Gastrointestinal Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Gastrointestinal Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Gastrointestinal Drugs Revenue Market Share by Region (2018-2024)
Table 23. Global Gastrointestinal Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Gastrointestinal Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Gastrointestinal Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Gastrointestinal Drugs Sales by Country (2018-2024) & (K Units)
Table 27. North America Gastrointestinal Drugs Sales by Country (2024-2029) & (K Units)
Table 28. North America Gastrointestinal Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Gastrointestinal Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Gastrointestinal Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Gastrointestinal Drugs Sales by Country (2018-2024) & (K Units)
Table 32. Europe Gastrointestinal Drugs Sales by Country (2024-2029) & (K Units)
Table 33. Europe Gastrointestinal Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Gastrointestinal Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Gastrointestinal Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Gastrointestinal Drugs Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Gastrointestinal Drugs Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Gastrointestinal Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Gastrointestinal Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Gastrointestinal Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Gastrointestinal Drugs Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Gastrointestinal Drugs Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Gastrointestinal Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Gastrointestinal Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Gastrointestinal Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Gastrointestinal Drugs Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Gastrointestinal Drugs Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Gastrointestinal Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Gastrointestinal Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Gastrointestinal Drugs Sales (K Units) by Type (2018-2024)
Table 51. Global Gastrointestinal Drugs Sales (K Units) by Type (2024-2029)
Table 52. Global Gastrointestinal Drugs Sales Market Share by Type (2018-2024)
Table 53. Global Gastrointestinal Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Gastrointestinal Drugs Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Gastrointestinal Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Gastrointestinal Drugs Revenue Market Share by Type (2018-2024)
Table 57. Global Gastrointestinal Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Gastrointestinal Drugs Price (USD/Unit) by Type (2018-2024)
Table 59. Global Gastrointestinal Drugs Price (USD/Unit) by Type (2024-2029)
Table 60. Global Gastrointestinal Drugs Sales (K Units) by Application (2018-2024)
Table 61. Global Gastrointestinal Drugs Sales (K Units) by Application (2024-2029)
Table 62. Global Gastrointestinal Drugs Sales Market Share by Application (2018-2024)
Table 63. Global Gastrointestinal Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Gastrointestinal Drugs Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Gastrointestinal Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Gastrointestinal Drugs Revenue Market Share by Application (2018-2024)
Table 67. Global Gastrointestinal Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Gastrointestinal Drugs Price (USD/Unit) by Application (2018-2024)
Table 69. Global Gastrointestinal Drugs Price (USD/Unit) by Application (2024-2029)
Table 70. AstraZeneca Corporation Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. AstraZeneca Gastrointestinal Drugs Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Sanofi Corporation Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. Sanofi Gastrointestinal Drugs Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Bayer Corporation Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. Bayer Gastrointestinal Drugs Product
Table 84. Bayer Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 88. Pfizer Gastrointestinal Drugs Product
Table 89. Pfizer Recent Developments/Updates
Table 90. GlaxoSmithKline Corporation Information
Table 91. GlaxoSmithKline Description and Business Overview
Table 92. GlaxoSmithKline Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 93. GlaxoSmithKline Gastrointestinal Drugs Product
Table 94. GlaxoSmithKline Recent Developments/Updates
Table 95. Teva Corporation Information
Table 96. Teva Description and Business Overview
Table 97. Teva Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 98. Teva Gastrointestinal Drugs Product
Table 99. Teva Recent Developments/Updates
Table 100. Zeria (Tillotts) Corporation Information
Table 101. Zeria (Tillotts) Description and Business Overview
Table 102. Zeria (Tillotts) Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 103. Zeria (Tillotts) Gastrointestinal Drugs Product
Table 104. Zeria (Tillotts) Recent Developments/Updates
Table 105. Perrigo Corporation Information
Table 106. Perrigo Description and Business Overview
Table 107. Perrigo Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 108. Perrigo Gastrointestinal Drugs Product
Table 109. Perrigo Recent Developments/Updates
Table 110. Boehringer Ingelheim Corporation Information
Table 111. Boehringer Ingelheim Description and Business Overview
Table 112. Boehringer Ingelheim Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Boehringer Ingelheim Gastrointestinal Drugs Product
Table 114. Boehringer Ingelheim Recent Developments/Updates
Table 115. Purdue Pharma Corporation Information
Table 116. Purdue Pharma Description and Business Overview
Table 117. Purdue Pharma Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. Purdue Pharma Gastrointestinal Drugs Product
Table 119. Purdue Pharma Recent Developments/Updates
Table 120. C.B. Fleet Corporation Information
Table 121. C.B. Fleet Description and Business Overview
Table 122. C.B. Fleet Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. C.B. Fleet Gastrointestinal Drugs Product
Table 124. C.B. Fleet Recent Developments/Updates
Table 125. Abbott Corporation Information
Table 126. Abbott Description and Business Overview
Table 127. Abbott Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 128. Abbott Gastrointestinal Drugs Product
Table 129. Abbott Recent Developments/Updates
Table 130. Jiangzhong Corporation Information
Table 131. Jiangzhong Description and Business Overview
Table 132. Jiangzhong Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 133. Jiangzhong Gastrointestinal Drugs Product
Table 134. Jiangzhong Recent Developments/Updates
Table 135. Xian-Janssen Corporation Information
Table 136. Xian-Janssen Description and Business Overview
Table 137. Xian-Janssen Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 138. Xian-Janssen Gastrointestinal Drugs Product
Table 139. Xian-Janssen Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Gastrointestinal Drugs Distributors List
Table 143. Gastrointestinal Drugs Customers List
Table 144. Gastrointestinal Drugs Market Trends
Table 145. Gastrointestinal Drugs Market Drivers
Table 146. Gastrointestinal Drugs Market Challenges
Table 147. Gastrointestinal Drugs Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gastrointestinal Drugs
Figure 2. Global Gastrointestinal Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Gastrointestinal Drugs Market Share by Type in 2022 & 2029
Figure 4. Prescription Gastrointestinal Drug Product Picture
Figure 5. OTC Gastrointestinal Drug Product Picture
Figure 6. Global Gastrointestinal Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Gastrointestinal Drugs Market Share by Application in 2022 & 2029
Figure 8. Chronic Gastritis
Figure 9. Functional Dyspepsia
Figure 10. Peptic Ulcer
Figure 11. Acute Gastroenteritis
Figure 12. Other
Figure 13. Global Gastrointestinal Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Gastrointestinal Drugs Market Size (2018-2029) & (US$ Million)
Figure 15. Global Gastrointestinal Drugs Sales (2018-2029) & (K Units)
Figure 16. Global Gastrointestinal Drugs Average Price (USD/Unit) & (2018-2029)
Figure 17. Gastrointestinal Drugs Report Years Considered
Figure 18. Gastrointestinal Drugs Sales Share by Manufacturers in 2022
Figure 19. Global Gastrointestinal Drugs Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Gastrointestinal Drugs Players: Market Share by Revenue in 2022
Figure 21. Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Gastrointestinal Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Gastrointestinal Drugs Sales Market Share by Country (2018-2029)
Figure 24. North America Gastrointestinal Drugs Revenue Market Share by Country (2018-2029)
Figure 25. the United States Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Gastrointestinal Drugs Sales Market Share by Country (2018-2029)
Figure 28. Europe Gastrointestinal Drugs Revenue Market Share by Country (2018-2029)
Figure 29. Germany Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. UK Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Gastrointestinal Drugs Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Gastrointestinal Drugs Revenue Market Share by Region (2018-2029)
Figure 36. China Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Gastrointestinal Drugs Sales Market Share by Country (2018-2029)
Figure 46. Latin America Gastrointestinal Drugs Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Gastrointestinal Drugs Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Gastrointestinal Drugs Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Gastrointestinal Drugs by Type (2018-2029)
Figure 56. Global Revenue Market Share of Gastrointestinal Drugs by Type (2018-2029)
Figure 57. Global Gastrointestinal Drugs Price (USD/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Gastrointestinal Drugs by Application (2018-2029)
Figure 59. Global Revenue Market Share of Gastrointestinal Drugs by Application (2018-2029)
Figure 60. Global Gastrointestinal Drugs Price (USD/Unit) by Application (2018-2029)
Figure 61. Gastrointestinal Drugs Value Chain
Figure 62. Gastrointestinal Drugs Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed